Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L37 pseudogene 2 (RPL37P2/PSANK1) is classified as a pseudogene located on chromosome 11q13.2 in the human genome[9]. It is a non-functional genomic sequence related to the ribosomal protein L37 gene, which is a component of the large 60S ribosomal subunit essential for protein synthesis[3][7]. Unlike the functional RPL37 gene, RPL37P2 does not produce a protein and has no established biological function or clinical significance as a therapeutic target. There are numerous pseudogenes for ribosomal proteins in the human genome, most of which do not encode functional proteins and are not considered drug targets[2][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L37 pseudogene 2 (RPL37P2).